DFTX earnings: a positive outcome, +7.9%

+7.9%Definium Therapeutics, Inc. (DFTX) →

On November 10, 2022, Definium Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.9% in the window around the event. It had already run -11.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$2.41

1d before

$2.60

Event day

$2.89

1d after

$2.86

5d after

Pre-catalyst setup

-11.4%

30-day run-up

6906%

30-day volatility

0.7×

volume spike

DFTX catalyst calendar More earningss Prediction track record Full catalyst calendar